Furthermore, a study conducted in the Kingdom of Saudi Arabia (KSA) showed that compliance rates for individuals with diabetes range from 60% to 80% for insulin and from 65% to 85% for oral antidiabetic drugs [37]. This evidence concerns the gene INS and diabetes mellitus.